Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of case definition algorithms for the ascertainment of congenital anomalies.
Nava de Escalante Y, Abayomi A, Langlois S, Ye X, Erickson A, Ngo H, Armour R, Okamoto R, Arbour L, Bedard T, Der K, Van Allen M, Skarsgard E, Lavoie M, Henry B. Nava de Escalante Y, et al. Among authors: der k. Birth Defects Res. 2023 Feb 1;115(3):302-317. doi: 10.1002/bdr2.2112. Epub 2022 Nov 11. Birth Defects Res. 2023. PMID: 36369700 Free PMC article.
Investigating an increase in microcephaly diagnoses in British Columbia.
Clarke QK, Xu C, Chu SW, Hutcheon JA, Martel SC, Janmohamed-Velani TA, Der K, Lee LS. Clarke QK, et al. Among authors: der k. Paediatr Child Health. 2019 Aug;24(5):331-332. doi: 10.1093/pch/pxz068. Epub 2019 Jun 18. Paediatr Child Health. 2019. PMID: 31379436 Free PMC article. No abstract available.
Survey of Mode of Delivery and Maternal and Perinatal Outcomes in Canada.
Yang J, Armson BA, Attenborough R, Carson GD, da Silva O, Heaman M, Janssen P, Murphy PA, Pasquier JC, Sauve R, Von Dadelszen P, Walker M, Lee SK; Canadian Mode of Delivery Study Group. Yang J, et al. J Obstet Gynaecol Can. 2022 Sep;44(9):960-971. doi: 10.1016/j.jogc.2022.04.017. Epub 2022 May 17. J Obstet Gynaecol Can. 2022. PMID: 35595024
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study.
Hamlin PA, Flinn IW, Wagner-Johnston N, Burger JA, Coffey GP, Conley PB, Michelson G, Leeds JM, Der K, Kim Y, Sabalvaro-Torres A, Birrell M, Pandey A, Curnutte JT, Patel MR. Hamlin PA, et al. Among authors: der k. Am J Hematol. 2019 Apr;94(4):E90-E93. doi: 10.1002/ajh.25387. Epub 2019 Jan 8. Am J Hematol. 2019. PMID: 30592080 Free article. Clinical Trial. No abstract available.
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.
Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang YL, Michelson G, Curnutte JT, Conley PB. Coffey GP, et al. Among authors: der k. Clin Cancer Res. 2019 Feb 15;25(4):1174-1184. doi: 10.1158/1078-0432.CCR-18-1047. Epub 2018 Oct 17. Clin Cancer Res. 2019. PMID: 30333224 Clinical Trial.
14 results